Nautilus Biotechnology In... (NAUT)
1.95
0.09 (4.84%)
At close: Jan 15, 2025, 2:25 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 5.71M | 3.42M | 2.84M | 2.35M | n/a | n/a |
| Gross Profit | -5.71M | -3.42M | -2.84M | -2.35M | n/a | n/a |
| Operating Income | -76.15M | -63.62M | -50.50M | -15.74M | -10.11K | -111.68M |
| Interest Income | 12.55M | 5.82M | 329.00K | n/a | n/a | n/a |
| Pretax Income | -63.67M | -57.92M | -50.31M | -15.62M | -9.62K | 626.60M |
| Net Income | -63.67M | -63.74M | -50.31M | -15.62M | -9.62K | 626.60M |
| Selling & General & Admin | 28.90M | 25.95M | 21.15M | 3.31M | 1.62K | 111.68M |
| Research & Development | 45.40M | 37.67M | 29.35M | 12.43M | 8.49K | n/a |
| Other Expenses | n/a | -122.00K | 183.00K | 125.00K | n/a | n/a |
| Operating Expenses | 76.15M | 63.62M | 50.50M | 15.74M | 9.62K | 111.68M |
| Interest Expense | n/a | 5.82M | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 76.15M | 63.62M | 50.50M | 15.74M | 9.62K | 111.68M |
| Income Tax | n/a | 5.82M | 2.61M | 2.14M | -171.31K | 738.12M |
| Shares Outstanding (Basic) | 124.92M | 124.59M | 84.46M | 29.96M | 7.19M | 7.19M |
| Shares Outstanding (Diluted) | 124.92M | 124.59M | 84.46M | 29.96M | 7.19M | 7.19M |
| EPS (Basic) | -0.51 | -0.51 | -0.6 | -0.52 | -0.00 | 87.18 |
| EPS (Diluted) | -0.51 | -0.51 | -0.6 | -0.52 | -0.00 | 87.18 |
| EBITDA | -74.30M | -54.51M | -47.47M | -13.27M | -9.56M | 626.60M |
| Depreciation & Amortization | 1.85M | 3.42M | 2.84M | 2.35M | 548.00K | 738.28M |